Angiodynamics (ANGO) Other Operating Expenses (2010 - 2026)

Angiodynamics has reported Other Operating Expenses for 17 years, with the latest figure at $30.1 million in Q1 2026.

• For the quarter ending Q1 2026, Other Operating Expenses changed N/A year-over-year to $30.1 million; the trailing twelve-month figure through Feb 2026 stood at $90.2 million (changed N/A YoY), and the FY2024 full-year result was $54.5 million, changed N/A from the prior year.
• Other Operating Expenses for Q1 2026 stood at $30.1 million, up from $29.4 million in the prior quarter.
• The five-year high for Other Operating Expenses was $47.8 million in Q3 2023, with the low at $6.7 million in Q1 2024.
• Historically, Other Operating Expenses has averaged $28.9 million across 5 years, with a median of $30.1 million in 2026.
• The largest YoY upside for Other Operating Expenses was 11.92% in 2022 against a maximum downside of 5.94% in 2022.
• Angiodynamics' Other Operating Expenses stood at $31.9 million in 2022, then soared by 50.01% to $47.8 million in 2023, then plunged by 86.09% to $6.7 million in 2024, then soared by 340.95% to $29.4 million in 2025, then advanced by 2.56% to $30.1 million in 2026.
• The last three Other Operating Expenses figures came in at $30.1 million (Q1 2026), $29.4 million (Q4 2025), and $30.8 million (Q3 2025), per Business Quant data.